日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prospective Cohort Study of Felzartamab in Rituximab-Resistant Primary Membranous Nephropathy

一项关于非扎单抗治疗利妥昔单抗耐药原发性膜性肾病的前瞻性队列研究

Trillini, Matias; Casiraghi, Federica; Gennarini, Alessia; Portalupi, Valentina; Marasà, Maddalena; Podestà, Manuel Alfredo; Prandini, Silvia; Nozza, Silvia; Todeschini, Marta; Pecoraro, Francesco; Mister, Marilena; Carrara, Fabiola; Stucchi, Nadia; Peracchi, Tobia; Fidone, Diego; Villa, Alessandro; Rubis, Nadia; Diadei, Olimpia; Martinetti, Davide; Remuzzi, Giuseppe; Ruggenenti, Piero

Prospective Cohort Study of Obinutuzumab in Rituximab-Resistant Primary Membranous Nephropathy

奥妥珠单抗治疗利妥昔单抗耐药原发性膜性肾病的前瞻性队列研究

Trillini, Matias; Portalupi, Valentina; Gennarini, Alessia; Surdi, Livia; Currado, Annachiara; Marasà, Maddalena; Podestà, Manuel Alfredo; Villa, Alessandro; Peracchi, Tobia; Fidone, Diego; Rubis, Nadia; Diadei, Olimpia; Guarinoni, Chiara; Casiraghi, Federica; Todeschini, Marta; Cugini, Daniela; Carrara, Fabiola; Martinetti, Davide; Rizzo, Paola; Remuzzi, Giuseppe; Ruggenenti, Piero

Randomized Trial of Dapagliflozin in Patients With Nondiabetic Stage 4 CKD

达格列净治疗非糖尿病4期慢性肾脏病患者的随机试验

Trillini, Matias; Villa, Alessandro; Perna, Annalisa; Peracchi, Tobia; Fidone, Diego; Rubis, Nadia; Guarinoni, Chiara; Martinetti, Davide; Chiappa, Annamaria; Gamba, Tiziano; Perticucci, Elena; Gambara, Vincenzo; Rota, Stefano; Stucchi, Nadia; Carrara, Fabiola; Remuzzi, Giuseppe; Ruggenenti, Piero

Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM).

间充质基质细胞(ORBCEL-M)疗法治疗糖尿病肾病的安全性和初步疗效:一项随机临床试验(NEPHSTROM)

Perico Norberto, Remuzzi Giuseppe, Griffin Matthew D, Cockwell Paul, Maxwell Alexander P, Casiraghi Federica, Rubis Nadia, Peracchi Tobia, Villa Alessandro, Todeschini Marta, Carrara Fabiola, Magee Bernadette A, Ruggenenti Piero L, Rota Stefano, Cappelletti Laura, McInerney Veronica, Griffin Tomás P, Islam Md Nahidul, Introna Martino, Pedrini Olga, Golay Josée, Finnerty Andrew A, Smythe Jon, Fibbe Willem E, Elliman Stephen J, O'Brien Timothy

Effects of Octreotide-Long-Acting Release Added-on Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease: Pilot, Randomized, Placebo-Controlled, Cross-Over Trial

奥曲肽长效缓释剂联合托伐普坦治疗常染色体显性多囊肾病患者的疗效:一项初步、随机、安慰剂对照、交叉试验

Trillini, Matias; Caroli, Anna; Perico, Norberto; Remuzzi, Andrea; Brambilla, Paolo; Villa, Giulia; Perna, Annalisa; Peracchi, Tobia; Rubis, Nadia; Martinetti, Davide; Caruso, Mariarosa; Leone, Valentina Fanny; Cugini, Daniela; Carrara, Fabiola; Remuzzi, Giuseppe; Ruggenenti, Piero

A phase I study of autologous mesenchymal stromal cells for severe steroid-dependent nephrotic syndrome

自体间充质干细胞治疗重度类固醇依赖性肾病综合征的I期研究

Vivarelli, Marina; Colucci, Manuela; Algeri, Mattia; Zotta, Federica; Emma, Francesco; L'Erario, Ines; Busutti, Marco; Rota, Stefano; Capelli, Chiara; Introna, Martino; Todeschini, Marta; Casiraghi, Federica; Perna, Annalisa; Peracchi, Tobia; De Salvo, Andrea; Rubis, Nadia; Locatelli, Franco; Remuzzi, Giuseppe; Ruggenenti, Piero

C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19

C5a 和 C5aR1 是多种临床疾病(从非典型溶血性尿毒综合征到 COVID-19)中微血管血小板聚集的关键驱动因素。

Aiello, Sistiana; Gastoldi, Sara; Galbusera, Miriam; Ruggenenti, Piero; Portalupi, Valentina; Rota, Stefano; Rubis, Nadia; Liguori, Lucia; Conti, Sara; Tironi, Matteo; Gamba, Sara; Santarsiero, Donata; Benigni, Ariela; Remuzzi, Giuseppe; Noris, Marina

A simple, home-therapy algorithm to prevent hospitalisation for COVID-19 patients: A retrospective observational matched-cohort study

一种预防新冠肺炎患者住院的简易居家治疗方案:一项回顾性观察性匹配队列研究

Suter, Fredy; Consolaro, Elena; Pedroni, Stefania; Moroni, Chiara; Pastò, Elena; Paganini, Maria Vittoria; Pravettoni, Grazia; Cantarelli, Umberto; Rubis, Nadia; Perico, Norberto; Perna, Annalisa; Peracchi, Tobia; Ruggenenti, Piero; Remuzzi, Giuseppe

Preventing microalbuminuria with benazepril, valsartan, and benazepril-valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) study

在伴有高正常白蛋白尿的糖尿病患者中,使用贝那普利、缬沙坦和贝那普利-缬沙坦联合疗法预防微量白蛋白尿:一项前瞻性、随机、开放标签、盲法终点(PROBE)研究

Ruggenenti, Piero; Cortinovis, Monica; Parvanova, Aneliya; Trillini, Matias; Iliev, Ilian P; Bossi, Antonio C; Belviso, Antonio; Aparicio, Maria C; Trevisan, Roberto; Rota, Stefano; Perna, Annalisa; Peracchi, Tobia; Rubis, Nadia; Martinetti, Davide; Prandini, Silvia; Gaspari, Flavio; Carrara, Fabiola; De Cosmo, Salvatore; Tonolo, Giancarlo; Mangili, Ruggero; Remuzzi, Giuseppe

Blood Pressure and Metabolic Effects of Acetyl-l-Carnitine in Type 2 Diabetes: DIABASI Randomized Controlled Trial

乙酰左旋肉碱对2型糖尿病患者血压和代谢的影响:DIABASI随机对照试验

Parvanova, Aneliya; Trillini, Matias; Podestà, Manuel A; Iliev, Ilian P; Aparicio, Carolina; Perna, Annalisa; Peraro, Francesco; Rubis, Nadia; Gaspari, Flavio; Cannata, Antonio; Ferrari, Silvia; Bossi, Antonio C; Trevisan, Roberto; Parameswaran, Sreejith; Chávez-Iñiguez, Jonathan S; Masnic, Fahrudin; Seck, Sidy Mohamed; Jiamjariyaporn, Teerayuth; Cortinovis, Monica; Perico, Luca; Sharma, Kanishka; Remuzzi, Giuseppe; Ruggenenti, Piero; Warnock, David G